{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:37:41Z","timestamp":1786984661365,"version":"build-2736575974"},"reference-count":119,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:00:00Z","timestamp":1437523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fundamental Research Funds"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.apsb.2015.07.006","type":"journal-article","created":{"date-parts":[[2015,9,6]],"date-time":"2015-09-06T10:00:13Z","timestamp":1441533613000},"page":"419-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["New small-molecule drug design strategies for fighting resistant influenza A"],"prefix":"10.1016","volume":"5","author":[{"given":"Zuyuan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2015.07.006_bib1","unstructured":"World Health Organization. Influenza (seasonal ) fact sheet N\u02da211. 2014. Available from: \u3008http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/\u3009."},{"key":"10.1016\/j.apsb.2015.07.006_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2015.07.006_bib3","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance-disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2015.07.006_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jiq005","article-title":"Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008\u20132010","volume":"203","author":"Sheu","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2015.07.006_bib5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/cmdc.201200155","article-title":"Recent advances in neuraminidase inhibitor development as anti-influenza drugs","volume":"7","author":"Feng","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.apsb.2015.07.006_bib6","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1074\/jbc.R500020200","article-title":"The M2 proton channels of influenza A and B viruses","volume":"281","author":"Pinto","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib7","doi-asserted-by":"crossref","first-page":"9903","DOI":"10.1021\/ja202288m","article-title":"How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?","volume":"133","author":"Leonov","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2015.07.006_bib8","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/AAC.00650-09","article-title":"Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance","volume":"53","author":"Furuse","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1099\/vir.2008.007260-0","article-title":"High prevalence of amantadine resistance among circulating European porcine influenza A viruses","volume":"90","author":"Krumbholz","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2015.07.006_bib11","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1021\/jm950891z","article-title":"Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2","volume":"39","author":"Kolocouris","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib12","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/S0960-894X(01)00388-2","article-title":"Novel 3-(2-adamantyl)pyrrolidines with potent activity against influenza A virus-identification of aminoadamantane derivatives bearing two pharmacophoric amine groups","volume":"11","author":"Stamatiou","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2015.07.006_bib13","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.bmc.2005.12.056","article-title":"Heterocyclic rimantadine analogues with antiviral activity","volume":"14","author":"Zoidis","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bmc.2009.11.047","article-title":"Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus","volume":"18","author":"Zarubaev","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib15","doi-asserted-by":"crossref","first-page":"13844","DOI":"10.1021\/ja2050666","article-title":"Exploring organosilane amines as potent inhibitors and structural probes of influenza A virus M2 proton channel","volume":"133","author":"Wang","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2015.07.006_bib16","doi-asserted-by":"crossref","first-page":"17987","DOI":"10.1021\/ja508461m","article-title":"Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant 531N mutant of the influenza A virus M2 proton channel","volume":"136","author":"Wu","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2015.07.006_bib17","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/jm901664a","article-title":"Identification of hits as matrix-2 protein inhibitors through the focused screening of a small primary amine library","volume":"53","author":"Hu","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.1191714","article-title":"Mechanisms of proton conduction and gating in influenza M2 proton channels from solid-state NMR","volume":"330","author":"Hu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.apsb.2015.07.006_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2010.10.010","article-title":"Discovery of highly potent agents against influenza A virus","volume":"46","author":"Zhao","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2012.09.001","article-title":"Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors","volume":"96","author":"Zhao","year":"2012","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib21","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1021\/bi9014488","article-title":"Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus","volume":"48","author":"Balannik","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2015.07.006_bib22","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/AAC.39.10.2204","article-title":"Growth impairment resulting from expression of influenza virus M2 protein in saccharomyces cerevisiae: identification of a novel inhibitor of influenza virus","volume":"39","author":"Kurtz","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06531","article-title":"Structure and mechanism of the M2 proton channel of influenza A virus","volume":"451","author":"Schnell","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib24","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","article-title":"Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium","volume":"78","author":"Matrosovich","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib25","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.79.18.11705-11715.2005","article-title":"Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication","volume":"79","author":"Suzuki","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib26","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1128\/JVI.00477-06","article-title":"Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses","volume":"80","author":"Yen","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"Von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib28","doi-asserted-by":"crossref","first-page":"II5","DOI":"10.1093\/jac\/dkq015","article-title":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations","volume":"65","author":"Davies","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib29","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/AAC.01718-10","article-title":"Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients","volume":"55","author":"Kohno","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib30","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1128\/AAC.00731-09","article-title":"CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract","volume":"53","author":"Koyama","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/jiq010","article-title":"Generation and characterization of recombinant pandemic influenza A (H1N1) viruses resistant to neuraminidase inhibitors","volume":"203","author":"Pizzorno","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2015.07.006_bib33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.apsb.2015.07.006_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.drudis.2012.06.002","article-title":"Recent progress in structure-based anti-influenza drug design","volume":"17","author":"Du","year":"2012","journal-title":"Drug Disc Today"},{"key":"10.1016\/j.apsb.2015.07.006_bib35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"Collins","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ncomms1114","article-title":"Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase","volume":"1","author":"Rudrawar","year":"2010","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2015.07.006_bib38","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1039\/c2ob25627d","article-title":"Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility","volume":"10","author":"Rudrawar","year":"2012","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib39","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1016\/j.bmc.2010.04.010","article-title":"Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses","volume":"18","author":"Wen","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib40","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1021\/jm500892k","article-title":"Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase","volume":"57","author":"Xie","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib41","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1021\/ja0723535","article-title":"Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design","volume":"129","author":"Amaro","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2015.07.006_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4155\/fmc.10.292","article-title":"Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode","volume":"3","author":"Kirchmair","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib43","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1021\/jm800455g","article-title":"A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase","volume":"52","author":"An","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/jm3009713","article-title":"Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors","volume":"56","author":"Feng","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib45","doi-asserted-by":"crossref","first-page":"11892","DOI":"10.1021\/ja073992i","article-title":"Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity","volume":"129","author":"Shie","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2015.07.006_bib46","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/jm980162u","article-title":"Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors","volume":"41","author":"Kim","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib47","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1021\/jm401977j","article-title":"Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors","volume":"57","author":"Mooney","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/jm401492x","article-title":"Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A","volume":"57","author":"Schade","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib49","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/jm901440f","article-title":"Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai","volume":"53","author":"Grienke","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib50","doi-asserted-by":"crossref","first-page":"e79293","DOI":"10.1371\/journal.pone.0079293","article-title":"Identification of traditional medicinal plant extracts with novel anti-influenza activity","volume":"8","author":"Rajasekaran","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2015.07.006_bib51","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1021\/np1002753","article-title":"C-methylated flavonoids from Cleistocalyx operculatus and their inhibitory effects on novel influenza A (H1N1) neuraminidase","volume":"73","author":"Dao","year":"2010","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2015.07.006_bib52","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.bmc.2008.06.049","article-title":"Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities","volume":"16","author":"Liu","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bmcl.2010.11.016","article-title":"Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata","volume":"21","author":"Dao","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2015.07.006_bib54","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/v4071144","article-title":"Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion","volume":"4","author":"Hamilton","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2015.07.006_bib55","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.carres.2006.06.017","article-title":"Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates","volume":"341","author":"Terabayashi","year":"2006","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib56","doi-asserted-by":"crossref","first-page":"e59623","DOI":"10.1371\/journal.pone.0059623","article-title":"Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses","volume":"8","author":"Job","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2015.07.006_bib57","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1074\/jbc.M112.437202","article-title":"Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus","volume":"288","author":"Hendricks","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib58","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2174\/092986707781696582","article-title":"Recent anti-influenza strategies in multivalent sialyloligosaccharides and sialylmimetics approaches","volume":"14","author":"Sun","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(02)00020-7","article-title":"Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection","volume":"55","author":"Gambaryan","year":"2002","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib60","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1021\/bi00063a007","article-title":"Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones","volume":"32","author":"Bodian","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2015.07.006_bib61","doi-asserted-by":"crossref","first-page":"e76363","DOI":"10.1371\/journal.pone.0076363","article-title":"Inhibition of influenza H7 hemagglutinin-mediated entry","volume":"8","author":"Antanasijevic","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2015.07.006_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/JVI.73.1.140-151.1999","article-title":"Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin","volume":"73","author":"Plotch","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s007050050552","article-title":"Identification of a novel HA conformational change inhibitor of human influenza virus","volume":"144","author":"Yoshimoto","year":"1999","journal-title":"Arch Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib64","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/JVI.02325-09","article-title":"Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin","volume":"84","author":"Vanderlinden","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib65","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/JVI.71.5.4062-4070.1997","article-title":"Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus","volume":"71","author":"Luo","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib67","doi-asserted-by":"crossref","first-page":"e15874","DOI":"10.1371\/journal.pone.0015874","article-title":"Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol","volume":"6","author":"Teissier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2015.07.006_bib68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2014.10.013","article-title":"Global geno-proteomic analysis reveals cross-continental sequence conservation and druggable sites among influenza virus polymerases","volume":"112","author":"Babar","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib69","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2005.06.003","article-title":"In vitro and in vivo influenza virus-inhibitory effects of viramidine","volume":"68","author":"Sidwell","year":"2005","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib71","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4149\/av_2013_02_113","article-title":"The RNA polymerase of influenza A virus: mechanisms of viral transcription and replication","volume":"57","author":"Fodor","year":"2013","journal-title":"Acta Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib73","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2174\/092986611796378675","article-title":"Free energy calculations and binding analysis of two potential anti-influenza drugs with polymerase basic protein-2 (PB2)","volume":"18","author":"Lv","year":"2011","journal-title":"Protein Peptide Lett"},{"key":"10.1016\/j.apsb.2015.07.006_bib74","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature07745","article-title":"The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit","volume":"458","author":"Dias","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib75","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nature07720","article-title":"Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site","volume":"458","author":"Yuan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib76","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1128\/AAC.38.12.2827","article-title":"Inhibition of cap (m-7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2, 4-dioxobutanoic acid compounds","volume":"38","author":"Tomassini","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib77","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/AAC.40.5.1189","article-title":"A novel antiviral agent which inhibits the endonuclease of influenza viruses","volume":"40","author":"Tomassini","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib78","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/jm020334u","article-title":"Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors","volume":"46","author":"Parkes","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib79","doi-asserted-by":"crossref","first-page":"e1002830","DOI":"10.1371\/journal.ppat.1002830","article-title":"Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease","volume":"8","author":"DuBois","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2015.07.006_bib80","doi-asserted-by":"crossref","first-page":"e1002831","DOI":"10.1371\/journal.ppat.1002831","article-title":"Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase","volume":"8","author":"Kowalinski","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2015.07.006_bib81","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.antiviral.2013.05.014","article-title":"Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions","volume":"99","author":"Palu","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib82","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nature07120","article-title":"Crystal structure of the polymerase PAC\u2013PB1N complex from an avian influenza H5N1 virus","volume":"454","author":"He","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib83","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07225","article-title":"The structural basis for an essential subunit interaction in influenza virus RNA polymerase","volume":"454","author":"Obayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2015.07.006_bib84","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1073\/pnas.1119817109","article-title":"Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase","volume":"109","author":"Muratore","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2015.07.006_bib85","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1021\/jm401560v","article-title":"Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly","volume":"56","author":"Massari","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib86","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1021\/jm500300r","article-title":"Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds","volume":"57","author":"Lepri","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chembiol.2005.12.002","article-title":"Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase","volume":"13","author":"Loregian","year":"2006","journal-title":"Chem Biol"},{"key":"10.1016\/j.apsb.2015.07.006_bib88","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1128\/AAC.01219-12","article-title":"Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses","volume":"56","author":"Muratore","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbagen.2011.11.003","article-title":"Structure-based discovery of anti-influenza virus A compounds among medicines","volume":"1820","author":"Fukuoka","year":"2012","journal-title":"Biochim Biophys Acta \u2013 Gen Subj"},{"key":"10.1016\/j.apsb.2015.07.006_bib90","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/emboj.2009.138","article-title":"Structural insight into the essential PB1\u2013PB2 subunit contact of the influenza virus RNA polymerase","volume":"28","author":"Sugiyama","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2015.07.006_bib91","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ymeth.2011.08.007","article-title":"Identification of influenza virus inhibitors which disrupt of viral polymerase protein\u2013protein interactions","volume":"55","author":"Chase","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.apsb.2015.07.006_bib92","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/febs.12107","article-title":"A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly","volume":"280","author":"Li","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2015.07.006_bib93","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1099\/0022-1317-83-4-723","article-title":"The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication","volume":"83","author":"Portela","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0854.2006.00507.x","article-title":"Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity","volume":"8","author":"Amorim","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.apsb.2015.07.006_bib95","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2014.01.023","article-title":"Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites","volume":"454\u2013455","author":"Kukol","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2015.07.006_bib96","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.02335-12","article-title":"Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus","volume":"57","author":"Lejal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib97","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nbt.1638","article-title":"Identification of influenza A nucleoprotein as an antiviral target","volume":"28","author":"Kao","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2015.07.006_bib98","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1073\/pnas.1107906108","article-title":"Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers","volume":"108","author":"Gerritz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2015.07.006_bib99","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/jm2013503","article-title":"Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza a agents targeting virus nucleoprotein","volume":"55","author":"Cheng","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2015.07.006_bib100","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1073\/pnas.1013592107","article-title":"High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity","volume":"107","author":"Su","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2015.07.006_bib101","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.03123-12","article-title":"Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-rab11 complexes in influenza A virus infection","volume":"87","author":"Amorim","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib102","first-page":"73","article-title":"The NS1 protein: a multitasking virulence factor","author":"Ayllon","year":"2015"},{"key":"10.1016\/j.apsb.2015.07.006_bib103","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1128\/JVI.06722-11","article-title":"Strain-specific contribution of NS1-activated phosphoinositide 3-kinase signaling to influenza A virus replication and virulence","volume":"86","author":"Ayllon","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib104","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/nar\/gks979","article-title":"The RNA-binding domain of influenzavirus non-structural protein-1 cooperatively binds to virus-specific RNA sequences in a structure-dependent manner","volume":"41","author":"Marc","year":"2013","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib105","doi-asserted-by":"crossref","first-page":"13093","DOI":"10.1073\/pnas.0805213105","article-title":"Structural basis for suppression of a host antiviral response by influenza A virus","volume":"105","author":"Das","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2015.07.006_bib106","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2009.04.006","article-title":"Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I","volume":"5","author":"Gack","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2015.07.006_bib107","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1073\/pnas.0910715107","article-title":"Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein","volume":"107","author":"Hale","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2015.07.006_bib108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.antiviral.2013.06.005","article-title":"The influenza virus NS1 protein as a therapeutic target","volume":"99","author":"Engel","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2015.07.006_bib109","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/JVI.01805-08","article-title":"Novel influenza virus NS1 antagonists block replication and restore innate immune function","volume":"83","author":"Basu","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib110","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s00894-014-2142-7","article-title":"Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus","volume":"20","author":"Ai","year":"2014","journal-title":"J Mol Model"},{"key":"10.1016\/j.apsb.2015.07.006_bib111","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1099\/vir.0.025015-0","article-title":"Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner","volume":"92","author":"Walkiewicz","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.apsb.2015.07.006_bib112","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1504\/IJBRA.2010.037985","article-title":"Discovery of novel influenza inhibitors targeting the interaction of dsRNA with the NS1 protein by structure-based virtual screening","volume":"6","author":"Ai","year":"2010","journal-title":"Int J Bioinform Res Appl"},{"key":"10.1016\/j.apsb.2015.07.006_bib113","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/1087057111431488","article-title":"Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay","volume":"17","author":"Cho","year":"2012","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.apsb.2015.07.006_bib114","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/1087057108318754","article-title":"Development of an HTS assay for the search of anti-influenza agents targeting the interaction of viral RNA with the NS1 protein","volume":"13","author":"Maroto","year":"2008","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.apsb.2015.07.006_bib115","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","article-title":"International Severe Acute Respiratory and Emerging Infection Consortium. Antiviral combinations for severe influenza","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apsb.2015.07.006_bib116","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice","volume":"12","author":"Ilyushina","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.apsb.2015.07.006_bib117","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.00933-09","article-title":"Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice","volume":"54","author":"Smee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib118","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/AAC.05529-11","article-title":"Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2015.07.006_bib119","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2475","article-title":"Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics","volume":"18","author":"Seo","year":"2013","journal-title":"Antivir Ther"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383515001148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383515001148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T09:15:27Z","timestamp":1653124527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383515001148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2211383515001148"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2015.07.006","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New small-molecule drug design strategies for fighting resistant influenza A","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}